Form D — Cyrus Biotechnology, Inc.
0001641241-26-000001 · filed May 8, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $3,000,000
- Total sold
- $1,481,812
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Cyrus Biotechnology, Inc.
- CIK
- 1641241
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 3005 1ST AVE
SEATTLE, WA 98121 - Phone
- 2062586561
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Lucas Nivon · Executive OfficerSEATTLE, WA Find on LinkedIn ↗
-
Mark Benjamin · Executive OfficerSEATTLE, WA Find on LinkedIn ↗
-
Yifan Song · DirectorSEATTLE, WA Find on LinkedIn ↗
-
Chad Waite · DirectorSEATTLE, WA Find on LinkedIn ↗
-
Anthony Manning · DirectorSEATTLE, WA Find on LinkedIn ↗
-
Ramakrishna Satyavolu · DirectorSEATTLE, WA Find on LinkedIn ↗
-
Jason Smith · DirectorSEATTLE, WA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗